Christopher E. Morgan
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Structural Biology top 5%
Papers in
-
- RNA and protein synthesis mechanisms 11
- RNA Research and Splicing 4
- Photosynthetic Processes and Mechanisms 3
- RNA modifications and cancer 3
-
- Antibiotic Resistance in Bacteria 7
- Co-authors
- Edward Yu (18 shared papers)Chih‐Chia Su (5 shared papers)Robert A. Bonomo (5 shared papers)Zhemin Zhang (8 shared papers)Philip A. Klenotic (3 shared papers)Blanton S. Tolbert (5 shared papers)Meng Cui (3 shared papers)Carol V. Robinson (1 shared paper)
- Journals
- mBio (7 papers)PLoS Biology (2 papers)Journal of Molecular Biology (2 papers)Nature Methods (1 paper)Molecular & Cellular Proteomics (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Christopher E. Morgan
23 papers receiving 601 citations
Peers
Comparison fields: 5 of 78
- Molecular Medicine 203
- Structural Biology 37
- Endocrinology 60
- Molecular Biology 346
- Pharmacology 73
Countries citing papers authored by Christopher E. Morgan
This map shows the geographic impact of Christopher E. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Morgan more than expected).
Fields of papers citing papers by Christopher E. Morgan
This network shows the impact of papers produced by Christopher E. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Morgan. The network helps show where Christopher E. Morgan may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher E. Morgan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 71 | |
| 2 | 2020 | 64 | |
| 3 | 2019 | 62 | |
| 4 | 2017 | 54 | |
| 5 | 2021 | 45 | |
| 6 | 2017 | 43 | |
| 7 | 2021 | 40 | |
| 8 | 2021 | 36 | |
| 9 | 2015 | 32 | |
| 10 | 2020 | 23 | |
| 11 | 2015 | 20 | |
| 12 | 2022 | 19 | |
| 13 | 2023 | 17 | |
| 14 | 2023 | 15 | |
| 15 | 2023 | 14 | |
| 16 | 2023 | 12 | |
| 17 | 2021 | 9 | |
| 18 | 2022 | 8 | |
| 19 | 2023 | 5 | |
| 20 | 2022 | 4 |
About Christopher E. Morgan
Christopher E. Morgan is a scholar working on Molecular Biology, Molecular Medicine, Genetics, Ecology and Endocrinology, having authored 23 papers that have together received 602 indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (11 papers), Antibiotic Resistance in Bacteria (7 papers), Bacterial Genetics and Biotechnology (6 papers), Bacteriophages and microbial interactions (5 papers), Escherichia coli research studies (5 papers), RNA Research and Splicing (4 papers), Photosynthetic Processes and Mechanisms (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Molecular Medicine (203 citations), Structural Biology (37 citations), Endocrinology (60 citations), Molecular Biology (346 citations) and Pharmacology (73 citations). Christopher E. Morgan has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Edward Yu, Chih‐Chia Su, Robert A. Bonomo, Zhemin Zhang, Philip A. Klenotic, Blanton S. Tolbert, Meng Cui, Carol V. Robinson, Jani Reddy Bolla and Derek J. Taylor. Their work appears in journals such as mBio, PLoS Biology, Journal of Molecular Biology, Nature Methods and Molecular & Cellular Proteomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.